| Staci Sengewalt, PT | |
|
1086 E Bethlehem Blvd, Wheeling, WV 26003-4961 | |
| (304) 238-9468 | |
| Not Available |
| Full Name | Staci Sengewalt |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 17 Years |
| Location | 1086 E Bethlehem Blvd, Wheeling, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548459167 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT870825 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crossroads Physical Therapy Pc | 5799057071 | 5 |
| Crossroads Physical Therapy Pc | 5799057071 | 5 |
News Archive
A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.
Women living in large urban areas are at a significantly higher risk of postpartum depression after five to 14 months of giving birth compared to those living in rural areas, according to a new Canadian study led by Women's College Hospital's Dr. Simone Vigod.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.
ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that it has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.
› Verified 8 days ago
| Provider Name | Wsb Rehabilitation Services Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396100418 PECOS PAC ID: 5294831053 Enrollment ID: O20160407000369 |
News Archive
A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.
Women living in large urban areas are at a significantly higher risk of postpartum depression after five to 14 months of giving birth compared to those living in rural areas, according to a new Canadian study led by Women's College Hospital's Dr. Simone Vigod.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.
ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that it has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.
› Verified 8 days ago
| Provider Name | Crossroads Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1437690021 PECOS PAC ID: 5799057071 Enrollment ID: O20200122000049 |
News Archive
A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.
Women living in large urban areas are at a significantly higher risk of postpartum depression after five to 14 months of giving birth compared to those living in rural areas, according to a new Canadian study led by Women's College Hospital's Dr. Simone Vigod.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.
ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that it has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.
› Verified 8 days ago
| Provider Name | At Home By Enhance Therapies Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124603246 PECOS PAC ID: 4183033210 Enrollment ID: O20231201000839 |
News Archive
A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.
Women living in large urban areas are at a significantly higher risk of postpartum depression after five to 14 months of giving birth compared to those living in rural areas, according to a new Canadian study led by Women's College Hospital's Dr. Simone Vigod.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.
ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that it has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Staci Sengewalt, PT 900 Wildflower Cir, Ste 903, Washington, PA 15301-9782 Ph: (724) 416-7172 | Staci Sengewalt, PT 1086 E Bethlehem Blvd, Wheeling, WV 26003-4961 Ph: (304) 238-9468 |
News Archive
A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.
Women living in large urban areas are at a significantly higher risk of postpartum depression after five to 14 months of giving birth compared to those living in rural areas, according to a new Canadian study led by Women's College Hospital's Dr. Simone Vigod.
Pharmaceuticals, Inc. today announced interim results of a randomized, open‐label, active-control multicenter Phase 2 study of oral ridaforolimus, an investigational mTOR inhibitor, in patients with metastatic or recurrent endometrial cancer. Based on this interim analysis, the study demonstrated a statistically significant improvement in the primary endpoint of median progression-free survival (PFS) in patients receiving single-agent ridaforolimus compared to patients receiving standard-of-care treatment.
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.
ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today that it has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.
› Verified 8 days ago
Nkemakolem Nwosu, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 316 Washington Ave, Apt. 106, Wheeling, WV 26003 Phone: 617-230-1890 | |
Curtis L Neel, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Wheeling Hospital Inc, 1 Medical Park, Wheeling, WV 26003 Phone: 304-243-3124 Fax: 304-243-6343 | |
Catherine F Sansone, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park, Wheeling Hospital Inc, Wheeling, WV 26003 Phone: 304-243-3124 | |
Billie J Johnston, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park, Wheeling Hospital Inc, Wheeling, WV 26003 Phone: 304-243-3124 | |
Emily J Eberle, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 Homestead Ave, Wheeling, WV 26003 Phone: 304-234-0559 | |
Medical Rehabilitative Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: One Community Street, Wheeling, WV 26003 Phone: 304-242-3933 Fax: 304-242-3833 | |
Anthony Jesse-james Howard, PT,DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 Homestead Ave, Wheeling, WV 26003 Phone: 304-234-0563 |